Product Information
NEO-BACIT-POLY-HC EYE OINTMENT is a generic product labeled by Bausch & Lomb Incorporated, priced at $5.5182 per GM under NDC 24208078555. Its NADAC has been published 588 times since Nov 28, 2013.
FDA first approved this application on Oct 30, 1995.
NEO-BACIT-POLY-HC EYE OINTMENT
Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and HydrocortisoneStrength
400; 10; 3.5; 10000 [USP'U]/g; mg/g; mg/g; [USP'U]/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208078555
Classification
Generic
Dosage Form
OINTMENT
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA064068FDA Approved
10/30/1995
On Market Since
10/30/1995
Pharmacological Classes
Price Statistics
The NADAC for NEO-BACIT-POLY-HC EYE OINTMENT has been published 588 times since Nov 28, 2013, and over the history we have for it it has declined 54.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.5182 per GM |
|---|---|
| All-time high | $14.3389 (Apr 13, 2016) |
| All-time low | $4.8193 (Apr 17, 2024) |
| 52-week high | $6.0725 |
| 52-week low | $5.1396 |
| Median price | $8.8469 |
| Average price | $9.8155 |
| Largest weekly change | +55.2% (Jun 18, 2014) |
| Weeks tracked | 588 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEO-BACIT-POLY-HC EYE OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for NEO-BACIT-POLY-HC EYE OINTMENT, manufactured by Bausch & Lomb Incorporated, is $5.5182 per GM (NDC 24208078555), effective Sep 30, 2026.
How has the price of NEO-BACIT-POLY-HC EYE OINTMENT changed over time?
Over the history we have for it, the NADAC for NEO-BACIT-POLY-HC EYE OINTMENT has declined 54.6%. It has been tracked across 588 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEO-BACIT-POLY-HC EYE OINTMENT?
Since Nov 28, 2013, the NADAC for NEO-BACIT-POLY-HC EYE OINTMENT has ranged from a low of $4.8193 (Apr 17, 2024) to a high of $14.3389 (Apr 13, 2016), with a median of $8.8469 per GM.
Are there cheaper alternatives to NEO-BACIT-POLY-HC EYE OINTMENT?
No other NADAC-published product currently shares the active ingredient and strength of NEO-BACIT-POLY-HC EYE OINTMENT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEO-BACIT-POLY-HC EYE OINTMENT?
NEO-BACIT-POLY-HC EYE OINTMENT (NDC 24208078555) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.